To verify that sICs and no other constituent represent the FcγRIIIA/CD16A-reactive component in the serum of COVID-19 patients, we analyzed serum-mediated FcγRIIIA/CD16A activation before and after PEG8000-precipitation. Here, FCGR3A is linked to COVID-19.